申请人:Pharmacia & Upjohn Company
公开号:US06685617B1
公开(公告)日:2004-02-03
The present invention relates to compound of formula (I), that are potent inhibitors of &agr;4&bgr;1 mediated adhesion to either VCAM or CS-1 and which could be useful for the treatment of inflammatory diseases. Specifically, the molecules of the present invention can be used for treating or preventing &agr;4&bgr;1 adhesion mediated conditions in a mammal such as a human. This method may comprise administering to a mammal or a human patient an effective amount of the compound or composition as explained in the present specification.
本发明涉及式(I)的化合物,它们是α4β1介导的对VCAM或CS-1的黏附的有效抑制剂,可用于治疗炎症性疾病。具体来说,本发明的分子可用于治疗或预防哺乳动物,如人类,中的α4β1介导的黏附状况。该方法可能包括向哺乳动物或人类患者施用本说明书中所述的化合物或组合物的有效量。